Shane Farragher
Director
Get their honest, personalized take on your startup.
Sign in to pitch Shane →At a glance
- Full Name
- Shane Patrick Farragher
- Title
- Director (investment professional; previously described as Principal)
- Firm
- Exponent Private Equity LLP
- Firm Type
- Private equity (mid-market buyout) — note: the stub label "Angel Investors / Seed Round" appears to be a mis-categorization; Exponent is an institutional buyout firm, not an angel/seed investor
- Investment Stage
- Mid-market control buyouts / growth equity (not seed)
- Check Size
- Exponent's Fund V targets businesses with enterprise values of roughly €150m–€500m; the firm is typically the first institutional investor
- Target Company Profile
- High-quality, established market-leading mid-market companies — corporate, family- and founder-owned "primaries" of scale
- Sector Focus
- Sector-agnostic with deep clusters in healthcare/pharma, technology & digital, consumer/food brands, media, and mission-critical infrastructure/engineering
- Geographic Focus
- Europe — UK, Ireland, Benelux and the Nordics
- Location
- London, United Kingdom
Background
Shane Farragher is an investment professional at Exponent Private Equity, the London-headquartered mid-market buyout firm he joined in July 2017. Originally from Galway, Ireland, he studied Economics and History at Trinity College Dublin and went on to earn an MSc in Economics from University College London. Before Exponent, he worked in private equity and investment roles at CVC Capital Partners and Bain Capital, two of the larger global buyout/credit platforms — giving him a deal background well above the angel/seed level the stub data suggests.
At Exponent, Farragher sits on the firm's investment side and has been actively involved across several of the firm's transactions, including Meadow (dairy and food ingredients), Dennis (specialist media/publishing), Gü (premium chilled desserts), Natara, and Ethos Engineering (sustainable, mission-critical data-centre design). He currently serves on the boards of Gü, Natara and Ethos Engineering, and works closely with Spotlight Sports Group. He previously sat on the board of Meadow.
Exponent itself was founded in 2004 by Tom Sweet-Escott and Hugh Richards (out of the former 3i buyouts team) and invests in established European mid-market businesses using a "good-to-growth" model — backing companies that are already market leaders and investing in their capabilities to drive revenue-led profit growth. The firm closed its fifth flagship fund at over €1 billion (c. £900m) and operates from offices in London, Dublin and Amsterdam.
Investment Thesis & Focus
- Institutional mid-market control buyouts, not angel/seed deals — typically backing businesses with enterprise values of ~€150m–€500m
- Targets established, market-leading European businesses that are corporate-, family- or founder-owned ("primaries"), often becoming the first institutional investor in the company
- Pursues a "good-to-growth" strategy: investing in management, capabilities and operations to deliver organic, revenue-driven profit growth rather than relying on financial engineering
- Sector breadth with real depth in healthcare/pharma, consumer & food brands, media, technology/digital consultancy, and mission-critical infrastructure/engineering
- Geographic focus on the UK, Ireland, Benelux and the Nordics, run from London, Dublin and Amsterdam
- Distinctive approach of integrating industrialists/operating partners into the investment and value-creation process
Notable Investments
- Gü — premium chilled desserts brand; Farragher is a current board member
- Natara — Exponent portfolio company; Farragher is a current board member
- Ethos Engineering — Irish sustainable, mission-critical data-centre and building-services engineering firm; Fund V investment, Farragher is a current board member
- Meadow — dairy/food ingredients and butter business; Farragher previously served on the board
- Dennis — specialist consumer media and publishing group (titles such as *The Week*); Exponent deal Farragher was involved in
- Spotlight Sports Group — sports media, content and betting/data business; Farragher works closely with the company
- Wider Exponent Fund V portfolio context: Chanelle Pharma (generic & veterinary pharmaceuticals), Kingsbridge Healthcare Group, and Hippo Digital (technology consultancy)
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.